{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T12:12:01Z","timestamp":1783944721793,"version":"3.55.0"},"reference-count":44,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"unspecified","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,6,30]]},"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Antimicrobial resistance (AMR) is a global public health threat, responsible for an estimated 35\u2009200 bacterial resistance attributable deaths in the UK in 2019. Social determinants of health (SDoH) drive inequities that influence health outcomes. We aimed to conduct a scoping review of the evidence of the association between the SDoH and AMR in the UK.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>A scoping review was conducted using search terms related to SDoH and AMR across multiple databases, supplemented by manual searches. This followed Arksey and O\u2019Malley\u2019s framework and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) guideline.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data sources<\/jats:title>\n                    <jats:p>A systematic search was conducted across SCOPUS, PubMed, Academic Search Premier, AMED, APA PsycArticles, APA PsycInfo, CINAHL Plus with Full Text, Humanities International and Web of Science.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Eligibility criteria<\/jats:title>\n                    <jats:p>Primary UK-based literature exploring SDoH in relation to infectious disease syndromes requiring antimicrobial therapy and reporting AMR were included. Studies from January 2020 onwards, published in English, across all populations were considered. Non-UK studies, reviews, studies not addressing AMR, laboratory-based research and non-human health contexts were excluded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data extraction and synthesis<\/jats:title>\n                    <jats:p>Records were screened against eligibility criteria with reasons for exclusion documented. Data were charted against a customised form capturing study characteristics and key findings. Findings were thematically categorised to generate narrative synthesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>21 outputs met the inclusion criteria. Older females and those from lower socioeconomic groups showed higher antibiotic use and resistance. Migrant populations were vulnerable to AMR through poor living conditions and limited healthcare access. Misconceptions about AMR were common among younger and socioeconomically disadvantaged populations. Prescribing practices reflected patient expectations, systemic pressures and healthcare gaps, while fragmentation between primary and secondary care limited coordinated management and policy implementation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>AMR in the UK is driven by social, economic and systemic factors, placing vulnerable groups at heightened risk. Sustainable and equitable control requires integrating SDoH through targeted interventions, public engagement and inclusive policymaking to meet national and global targets.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-114037","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T11:40:11Z","timestamp":1783942811000},"page":"e114037","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Social determinants of health and antimicrobial resistance in the UK: a scoping review"],"prefix":"10.1136","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-8058-2168","authenticated-orcid":false,"given":"Tasleem","family":"Damani","sequence":"first","affiliation":[{"name":"School of Health Sciences, Faculty of Education, Health & Human Sciences, University of Greenwich, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Clark","sequence":"additional","affiliation":[{"name":"Institute for Lifecourse Development, Faculty of Education, Health & Human Sciences, University of Greenwich, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Osman","sequence":"additional","affiliation":[{"name":"Public Health, Faculty of Education, Health & Human Sciences, University of Greenwich, London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"2026071304400781000_16.7.e114037.1","unstructured":"Institute for Health Metrics and Evaluation . Antimicrobial resistance (AMR). Available: https:\/\/www.healthdata.org\/research-analysis\/health-topics\/antimicrobial-resistance-amr [Accessed 10 Jun 2025]."},{"key":"2026071304400781000_16.7.e114037.2","unstructured":"World Health Organization . Antimicrobial Resistance, 2023. Available: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antimicrobial-resistance"},{"key":"2026071304400781000_16.7.e114037.3","unstructured":"Dahlgren G , Whitehead M . Policies and strategies to promote social equity in health. Stockholm Institute of Future Studies; 1991."},{"key":"2026071304400781000_16.7.e114037.4","unstructured":"World Health Organization . Social determinants of health. 2025. Available: https:\/\/www.who.int\/health-topics\/social-determinants-of-health#tab=tab_1 [Accessed 11 Jun 2025]."},{"key":"2026071304400781000_16.7.e114037.5","unstructured":"HM Government . Confronting antimicrobial resistance 2024 to 2029. 2024."},{"key":"2026071304400781000_16.7.e114037.6","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv229"},{"key":"2026071304400781000_16.7.e114037.7","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e37563","article-title":"Trends and geographical variations in outpatient antimicrobial consumption in Ireland in relation to socio-economic deprivation","volume":"10","author":"Garz\u00f3n-Orjuela","year":"2024","journal-title":"Heliyon"},{"key":"2026071304400781000_16.7.e114037.8","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s10096-019-03804-8","article-title":"Low antimicrobial resistance in general practice patients in Rotterdam, the city with the largest proportion of immigrants in the Netherlands","volume":"39","author":"Honsbeek","year":"2020","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2026071304400781000_16.7.e114037.9","unstructured":"UK Health Security Agency . Antibiotic resistant infections and associated deaths increase. 2023. Available: https:\/\/www.gov.uk\/government\/news\/antibiotic-resistant-infections-and-associated-deaths-increase [Accessed 17 Jun 2025]."},{"key":"2026071304400781000_16.7.e114037.10","unstructured":"Marmot M . Healthy Lives The Marmot Review. 2010."},{"key":"2026071304400781000_16.7.e114037.11","unstructured":"Public Health England . Disparities in the risk and outcomes of COVID-19. 2020."},{"key":"2026071304400781000_16.7.e114037.12","doi-asserted-by":"publisher","DOI":"10.1080\/1364557032000119616"},{"key":"2026071304400781000_16.7.e114037.13","doi-asserted-by":"crossref","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"key":"2026071304400781000_16.7.e114037.14","doi-asserted-by":"publisher","DOI":"10.7326\/M18-0850"},{"key":"2026071304400781000_16.7.e114037.15","doi-asserted-by":"publisher","DOI":"10.1111\/hex.13102"},{"key":"2026071304400781000_16.7.e114037.16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232903","article-title":"Antimicrobial resistance associations with national primary care antibiotic stewardship policy: Primary care-based, multilevel analytic study","volume":"15","author":"Hammond","year":"2020","journal-title":"PLoS One"},{"key":"2026071304400781000_16.7.e114037.17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s40258-019-00516-0","article-title":"A Multinational European Study of Patient Preferences for Novel Diagnostics to Manage Antimicrobial Resistance","volume":"18","author":"Mott","year":"2020","journal-title":"Appl Health Econ Health Policy"},{"key":"2026071304400781000_16.7.e114037.18","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-020-8383-8","article-title":"Views of health care professionals and policy-makers on the use of surveillance data to combat antimicrobial resistance","volume":"20","author":"Al-Haboubi","year":"2020","journal-title":"BMC Public Health"},{"key":"2026071304400781000_16.7.e114037.19","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2018-053912"},{"key":"2026071304400781000_16.7.e114037.20","doi-asserted-by":"crossref","DOI":"10.1016\/j.infpip.2020.100060","article-title":"Aston University\u2019s Antimicrobial Resistance (AMR) Roadshow: raising awareness and embedding knowledge of AMR in key stage 4 learners","volume":"2","author":"Ahmed","year":"2020","journal-title":"Infect Prev Pract"},{"key":"2026071304400781000_16.7.e114037.21","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa194"},{"key":"2026071304400781000_16.7.e114037.22","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/09581596.2020.1725444","article-title":"Antimicrobial resistance as a problem of values? Views from three continents","volume":"31","author":"Broom","year":"2021","journal-title":"Crit Public Health"},{"key":"2026071304400781000_16.7.e114037.23","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-021-11018-x","article-title":"Knowledge about infections is associated with antibiotic use: cross-sectional evidence from the health survey Northern Ireland","volume":"21","author":"Shebehe","year":"2021","journal-title":"BMC Public Health"},{"key":"2026071304400781000_16.7.e114037.24","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlab039","article-title":"Knowledge and attitudes of adolescents towards the human microbiome and antibiotic resistance: a qualitative study","volume":"3","author":"Hayes","year":"2021","journal-title":"JAC Antimicrob Resist"},{"key":"2026071304400781000_16.7.e114037.25","doi-asserted-by":"crossref","first-page":"i5","DOI":"10.1093\/jacamr\/dlab052","article-title":"Antibiotic resistance during and beyond COVID-19","volume":"3","author":"Livermore","year":"2021","journal-title":"JAC Antimicrob Resist"},{"key":"2026071304400781000_16.7.e114037.26","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-022-07768-7","article-title":"E. coli bacteraemia and antimicrobial resistance following antimicrobial prescribing for urinary tract infection in the community","volume":"22","author":"McCowan","year":"2022","journal-title":"BMC Infect Dis"},{"key":"2026071304400781000_16.7.e114037.27","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics11101434","article-title":"Antimicrobial Resistance Policy Protagonists and Processes-A Qualitative Study of Policy Advocacy and Implementation","volume":"11","author":"Chan","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"2026071304400781000_16.7.e114037.28","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlac083","article-title":"Hardwiring antimicrobial resistance mitigation into global policy","volume":"4","author":"Thornber","year":"2022","journal-title":"JAC Antimicrob Resist"},{"key":"2026071304400781000_16.7.e114037.29","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2023.28.47.2300100","article-title":"Assessing the impact of a national social marketing campaign for antimicrobial resistance on public awareness, attitudes, and behaviour, and as a supportive tool for healthcare professionals, England, 2017 to 2019","volume":"28","author":"Gilham","year":"2023","journal-title":"Euro Surveill"},{"key":"2026071304400781000_16.7.e114037.30","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.1655","article-title":"Migrants\u2019 living conditions, perceived health needs and implications for the use of antibiotics and antimicrobial resistance in the United Kingdom: A qualitative study","volume":"6","author":"Nanakali","year":"2023","journal-title":"Health Sci Rep"},{"key":"2026071304400781000_16.7.e114037.31","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jgar.2023.08.011","article-title":"The critical need to include migrant populations in the fight against antimicrobial resistance","volume":"35","author":"Bellizzi","year":"2023","journal-title":"J Glob Antimicrob Resist"},{"key":"2026071304400781000_16.7.e114037.32","doi-asserted-by":"crossref","DOI":"10.1186\/s41182-023-00524-w","article-title":"The global antimicrobial resistance response effort must not exclude marginalised populations","volume":"51","author":"Adebisi","year":"2023","journal-title":"Trop Med Health"},{"key":"2026071304400781000_16.7.e114037.33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/20514158221095672","article-title":"Prevalence of asymptomatic bacteriuria among pregnant women and changes in antibiotic resistance: a 6-year retrospective study","volume":"17","author":"Cotton","year":"2024","journal-title":"J Clin Urol"},{"key":"2026071304400781000_16.7.e114037.34","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(24)02012-9","article-title":"National reporting on factors associated with health inequalities and infection, antimicrobial resistance and consumption rates in England: 2018\u20132022","volume":"404","author":"Gilham","year":"2024","journal-title":"The Lancet"},{"key":"2026071304400781000_16.7.e114037.35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41562-023-01762-y","article-title":"We must harness the power of social and behavioural science against the growing pandemic of antimicrobial resistance","volume":"8","author":"Sirota","year":"2024","journal-title":"Nat Hum Behav"},{"key":"2026071304400781000_16.7.e114037.36","unstructured":"United Nations . Goal 3: good health and well-being. ensure healthy lives and promote well-being for all at all ages. 2025. Available: https:\/\/sdgs.un.org\/goals\/goal3#targets_and_indicators [Accessed 4 Jul 2025]."},{"key":"2026071304400781000_16.7.e114037.37","unstructured":"UK Health Security Agency . Surveillance of bloodstream infections in critical care units, England: May 2016 to March 2024 report. 2025."},{"key":"2026071304400781000_16.7.e114037.38","unstructured":"World Health Organization . People-centred approach to addressing antimicrobial resistance in human health: WHO core package of interventions to support national action plans. 2023."},{"key":"2026071304400781000_16.7.e114037.39","unstructured":"National Institute for Health and Care Excellence . Antimicrobial stewardship: changing risk-related behaviours in the general population NICE guideline. 2017."},{"key":"2026071304400781000_16.7.e114037.40","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.n129","article-title":"Covid-19 pandemic and the social determinants of health","volume":"372","author":"Paremoer","year":"2021","journal-title":"BMJ"},{"key":"2026071304400781000_16.7.e114037.41","doi-asserted-by":"crossref","first-page":"e260","DOI":"10.1016\/S2589-7500(20)30317-4","article-title":"Health data poverty: an assailable barrier to equitable digital health care","volume":"3","author":"Ibrahim","year":"2021","journal-title":"Lancet Digit Health"},{"key":"2026071304400781000_16.7.e114037.42","unstructured":"NHS England . Digital vision for antimicrobial stewardship in England. 2025."},{"key":"2026071304400781000_16.7.e114037.43","unstructured":"National Institute for Health and Care Excellence . Antimicrobial stewardship: systems and processes for effective antimicrobial medicine use NICE guideline. 2015."},{"key":"2026071304400781000_16.7.e114037.44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177306","article-title":"Taking stock of the social determinants of health: A scoping review","volume":"12","author":"Lucyk","year":"2017","journal-title":"PLoS One"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-114037","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T11:40:17Z","timestamp":1783942817000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-114037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":44,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,13]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1136\/bmjopen-2025-114037"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-114037","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}